RECRUITINGOBSERVATIONAL
Exploratory Study on the Timing of Multiple Sclerosis (MS) Symptoms
Exploratory Study on the Timing of MS Symptoms
About This Trial
The investigators' overall hypothesis is that appearance or worsening of relapsing-remitting multiple sclerosis (RR-MS) symptoms are affected by various factors including stress, hormonal cycles, illness and missed medications.
Who May Be Eligible (Plain English)
Who May Qualify:
- females
- diagnosed with relapsing-remitting multiple sclerosis
Who Should NOT Join This Trial:
- male
- no diagnosis of relapsing-remitting MS
- diagnosis of any other autoimmune conditions (where your immune system attacks your own body) or fibromyalgia
- peri-, post-, or surgically menopausal
- pregnant within past year or nursing
- history of chemotherapy
- on experimental medications
- treatment with steroids in the last 30 days
Always talk to your doctor about whether this trial is right for you.
Original Eligibility Criteria
View original clinical language
Inclusion Criteria:
* females
* diagnosed with relapsing-remitting multiple sclerosis
Exclusion Criteria:
* male
* no diagnosis of relapsing-remitting MS
* diagnosis of any other autoimmune disease or fibromyalgia
* peri-, post-, or surgically menopausal
* pregnant within past year or nursing
* history of chemotherapy
* on experimental medications
* treatment with steroids in the last 30 days
Locations (1)
University of Louisville (recruiting nationwide)
Louisville, Kentucky, United States